Danielle Antalffy analyst UBS

Currently out of the existing stock ratings of Danielle Antalffy, 149 are a BUY (60.57%), 87 are a HOLD (35.37%), 10 are a SELL (4.07%).

Danielle Antalffy

Work Performance Price Targets & Ratings Chart

Analyst Danielle Antalffy, currently employed at UBS, carries an average stock price target met ratio of 73.57% that have a potential upside of 23.42% achieved within 224 days.

Danielle Antalffy’s has documented 529 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on ATRC, AtriCure at 30-Oct-2024.

Wall Street Analyst Danielle Antalffy

Analyst best performing recommendations are on BFLY (BUTTERFLY NETWORK).
The best stock recommendation documented was for BFLY (BUTTERFLY NETWORK) at 3/29/2023. The price target of $2.25 was fulfilled within 6 days with a profit of $0.6 (36.36%) receiving and performance score of 60.61.

Average potential price target upside

ABMD ABIOMED ABT Abbott Laboratories BSX Boston Scientific Corp DXCM DexCom EW Edwards Lifesciences Corp INGN Inogen JNJ Johnson & Johnson MDT Medtronic PLC NVRO Nevro Corp PODD Insulet TNDM Tandem Diabetes Care CSII Cardiovascular Systems VCEL Vericel Corp Ord ATRC AtriCure AXNX Axonics Modulation Technologies BAX Baxter International INSP Inspire Medical Systems NARI Inari Medical  SENS Senseonics Holdings SILK Silk Road Medical SWAV Shockwave Medical TMCI Treace Medical Concepts UTRS Minerva Surgical VCRA Vocera Communications LNTH Lantheus Holdings ZBH Zimmer Biomet Holdings BFLY Butterfly Network ISRG Intuitive Surgical NVCN Neovasc PRCT Procept Biorobotics Corp SYK Stryker INMD InMode Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$388

$6.98 (1.83%)

$355

2 years 1 months 23 days ago
(02-Nov-2022)

2/5 (40%)

$14.49 (3.88%)

88

Hold

$380

$-1.02 (-0.27%)

$235

2 years 1 months 23 days ago
(02-Nov-2022)

1/2 (50%)

$6.49 (1.74%)

36

Hold

$380

$-1.02 (-0.27%)

$350

2 years 1 months 24 days ago
(01-Nov-2022)

24/41 (58.54%)

$2.18 (0.58%)

138

Buy

$300

$-81.02 (-21.26%)

$425

2 years 2 months 13 days ago
(12-Oct-2022)

1/2 (50%)

$57.23 (23.57%)

20

Sell

$235

$-146.02 (-38.32%)

$275

2 years 5 months 10 days ago
(15-Jul-2022)

6/8 (75%)

$-33.23 (-12.39%)

142

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Danielle Antalffy is most bullish on?

Potential upside of $31.77 has been obtained for ABT (ABBOTT LABORATORIES)

Which stock is Danielle Antalffy is most reserved on?

Potential downside of -$0.12 has been obtained for ZBH (ZIMMER BIOMET HOLDINGS)

What Year was the first public recommendation made by Danielle Antalffy?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?